216 related articles for article (PubMed ID: 32122647)
1. Role of submucosal glands in the development and progression of carcinoma in Barrett's oesophagus.
Johncilla M; Odze RD; Agoston AT
Pathology; 2020 Apr; 52(3):310-317. PubMed ID: 32122647
[TBL] [Abstract][Full Text] [Related]
2. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
3. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.
Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH
Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa.
Going JJ; Keith WN; Neilson L; Stoeber K; Stuart RC; Williams GH
Gut; 2002 Mar; 50(3):373-7. PubMed ID: 11839717
[TBL] [Abstract][Full Text] [Related]
5. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
Tsibouris P; Hendrickse MT; Isaacs PE
Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
[TBL] [Abstract][Full Text] [Related]
6. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence.
Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041
[TBL] [Abstract][Full Text] [Related]
7. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
[TBL] [Abstract][Full Text] [Related]
8. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk in Barrett's oesophagus.
Dias Pereira A; Suspiro A; Chaves P
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
[TBL] [Abstract][Full Text] [Related]
10. Distribution of laminins in the basement membranes of the upper gastrointestinal tract and Barrett's oesophagus.
Dave U; Thursz MR; Ebrahim HY; Burke MM; Townsend ER; Walker MM
J Pathol; 2004 Mar; 202(3):299-304. PubMed ID: 14991894
[TBL] [Abstract][Full Text] [Related]
11. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression.
Fitzgerald RC; Lascar R; Triadafilopoulos G
Aliment Pharmacol Ther; 2001 Mar; 15(3):269-76. PubMed ID: 11207503
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus.
Krishnadath KK; Tilanus HW; van Blankenstein M; Bosman FT; Mulder AH
J Pathol; 1995 Feb; 175(2):175-80. PubMed ID: 7738712
[TBL] [Abstract][Full Text] [Related]
13. Barrett's oesophagus: the new endoscopic modalities have a future.
Deviere J
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
[TBL] [Abstract][Full Text] [Related]
14. Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study.
Arul GS; Moorghen M; Myerscough N; Alderson DA; Spicer RD; Corfield AP
Gut; 2000 Dec; 47(6):753-61. PubMed ID: 11076872
[TBL] [Abstract][Full Text] [Related]
15. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
[TBL] [Abstract][Full Text] [Related]
16. Single cell RNA-seq reveals profound transcriptional similarity between Barrett's oesophagus and oesophageal submucosal glands.
Owen RP; White MJ; Severson DT; Braden B; Bailey A; Goldin R; Wang LM; Ruiz-Puig C; Maynard ND; Green A; Piazza P; Buck D; Middleton MR; Ponting CP; Schuster-Böckler B; Lu X
Nat Commun; 2018 Oct; 9(1):4261. PubMed ID: 30323168
[TBL] [Abstract][Full Text] [Related]
17. External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia.
Kunzmann AT; Thrift AP; Johnston BT; McManus DT; Gavin AT; Turkington RC; Coleman HG
Aliment Pharmacol Ther; 2019 May; 49(10):1274-1281. PubMed ID: 30950101
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression.
Jankowski J; McMenemin R; Yu C; Hopwood D; Wormsley KG
Gut; 1992 May; 33(5):587-91. PubMed ID: 1351861
[TBL] [Abstract][Full Text] [Related]
19. The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barrett's mucosa to adenocarcinoma of the oesophagus.
Griffin M; Sweeney EC
Histopathology; 1987 Jan; 11(1):53-62. PubMed ID: 2881873
[TBL] [Abstract][Full Text] [Related]
20. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
Fitzgerald RC
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
